Serum macrophage migration inhibitory factor levels are associated with infarct volumes and long-term outcomes in patients with acute ischemic stroke

References

• Bonita R, Mendis S, Truelsen T, et al. The global stroke initiative. Lancet Neurol 2004;3:391–3.
   PubMed Web of Science ®Google Scholar
• Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke 2008;39:1668–74.
   PubMed Web of Science ®Google Scholar
• Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009;27:165–97.
   PubMed Web of Science ®Google Scholar
• Ma A, Pan X, Xing Y, et al. Elevation of serum CXCL16 level correlates well with atherosclerotic ischemic stroke. Arch Med Sci 2014;10:47–52.
   PubMed Web of Science ®Google Scholar
• van der Vorst EP, Doring Y, Weber C. Chemokines and their receptors in atherosclerosis. J Mol Med 2015;93:963–71.
   PubMed Web of Science ®Google Scholar
• Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007;184:53–68.
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A, Pecoraro R, Di Raimondo D, et al. Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome. Diabetol Metab Syndr 2014;6:28.
   PubMed Web of Science ®Google Scholar
• Tillmann S, Bernhagen J, Noels H. Arrest functions of the MIF ligand/receptor axes in atherogenesis. Front Immunol 2013;4:115.
   PubMed Web of Science ®Google Scholar
• Asare Y, Schmitt M, Bernhagen J. The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis. Thromb Haemost 2013;109:391–8.
   PubMed Web of Science ®Google Scholar
• Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003;3:791–800.
   PubMed Web of Science ®Google Scholar
• Kim KW, Kim HR. Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis. Korean J Intern Med 2016;31:634–42.
   Web of Science ®Google Scholar
• Brennan-Bourdon LM, De la Cruz-Mosso U, Reyes-Castillo Z, et al. MIF and TNFalpha serum levels in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: a cross-sectional study. Immunopharmacol Immunotoxicol 2015;37:207–13.
   PubMed Web of Science ®Google Scholar
• Chen Z, Ma T, Huang C, et al. MIF, a potential therapeutic target for rheumatoid arthritis? Rheumatol Int 2014;34:1481–2.
   PubMed Web of Science ®Google Scholar
• Yang J, Li Y, Zhang X. Meta-analysis of macrophage migration inhibitory factor (MIF) gene -173G/C polymorphism and inflammatory bowel disease (IBD) risk. Int J Clin Exp Med 2015;8:9570–4.
   PubMed Web of Science ®Google Scholar
• Burger-Kentischer A, Goebel H, Seiler R, et al. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 2002;105:1561–6.
   PubMed Web of Science ®Google Scholar
• Burger-Kentischer A, Gobel H, Kleemann R, et al. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis 2006;184:28–38.
   PubMed Web of Science ®Google Scholar
• Lin SG, Yu XY, Chen YX, et al. De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res 2000;87:1202–8.
   PubMed Web of Science ®Google Scholar
• Nishio Y, Koda M, Hashimoto M, et al. Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice. Acta Neuropathol (Berl) 2009;117:321–8.
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Nishihira J, Tada M, et al. Induction of macrophage migration inhibitory factor messenger ribonucleic acid in rat forebrain by reperfusion. Neurosurgery 1997;41:648–53.
   PubMed Web of Science ®Google Scholar
• Inacio AR, Ruscher K, Leng L, et al. Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J Cereb Blood Flow Metab 2011;31:1093–106.
   PubMed Web of Science ®Google Scholar
• Wang L, Zis O, Ma G, et al. Upregulation of macrophage migration inhibitory factor gene expression in stroke. Stroke 2009;40:973–6.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zis O, Ly PT, et al. Down-regulation of MIF by NFkappaB under hypoxia accelerated neuronal loss during stroke. FASEB J 2014;28:4394–407.
   PubMed Web of Science ®Google Scholar
• Zis O, Zhang S, Dorovini-Zis K, et al. Hypoxia signaling regulates macrophage migration inhibitory factor (MIF) expression in stroke. Mol Neurobiol 2015;51:155–67.
   PubMed Web of Science ®Google Scholar
• Adams HP, Jr., Biller J. Classification of subtypes of ischemic stroke: history of the trial of org 10172 in acute stroke treatment classification. Stroke 2015;46:e114–7.
   PubMed Web of Science ®Google Scholar
• Brott T, Adams HP, Jr., Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864–70.
   PubMed Web of Science ®Google Scholar
• Sims JR, Gharai LR, Schaefer PW, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009;72:2104–10.
   PubMed Web of Science ®Google Scholar
• Bernhagen J, Calandra T, Mitchell RA, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756–9.
   PubMed Web of Science ®Google Scholar
• Bacher M, Meinhardt A, Lan HY, et al. MIF expression in the rat brain: implications for neuronal function. Mol Med 1998;4:217–30.
   PubMed Web of Science ®Google Scholar
• Bank M, Stein A, Sison C, et al. Elevated circulating levels of the pro-inflammatory cytokine macrophage migration inhibitory factor in individuals with acute spinal cord injury. Arch Phys Med Rehabil 2015;96:633–44.
   PubMed Web of Science ®Google Scholar
• Yu CM, Lau CP, Lai KW, et al. Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol 2001;88:774–7.
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A, Pecoraro R, Di Raimondo D, et al. Stroke subtypes and their possible implication in stroke prevention drug strategies. Curr Vasc Pharmacol 2013;11:824–37.
   PubMed Web of Science ®Google Scholar
• Buck BH, Liebeskind DS, Saver JL, et al. Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke. Arch Neurol 2007;64:1287–91.
   PubMedGoogle Scholar
• Liu P, Xiang JW, Jin SX. Serum CXCL12 levels are associated with stroke severity and lesion volumes in stroke patients. Neurol Res 2015;37:853–8.
   PubMed Web of Science ®Google Scholar
• Chan W, White DA, Wang XY, et al. Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc 2013;2:e000226.
   Web of Science ®Google Scholar
• Galvao I, Dias AC, Tavares LD, et al. Macrophage migration inhibitory factor drives neutrophil accumulation by facilitating IL-1beta production in a murine model of acute gout. J Leukoc Biol 2016;99:1035–43.
   PubMed Web of Science ®Google Scholar
• Santos LL, Fan H, Hall P, et al. Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice. Arthritis Rheum 2011;63:960–70.
   PubMed Web of Science ®Google Scholar
• Buck BH, Liebeskind DS, Saver JL, et al. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 2008;39:355–60.
   PubMed Web of Science ®Google Scholar
• Kim YS, Baek W, Kim MK, et al. Association between serum stromal cell-derived factor-1alpha and long-term outcome of acute ischemic stroke. Eur Neurol 2012;67:363–9.
   PubMed Web of Science ®Google Scholar
• Inacio AR, Ruscher K, Wieloch T. Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke. Neurobiol Dis 2011;41:270–8.
   PubMed Web of Science ®Google Scholar
• Turtzo LC, Li J, Persky R, et al. Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice. Neurobiol Dis 2013;54:421–31.
   PubMed Web of Science ®Google Scholar
• Liehn EA, Kanzler I, Konschalla S, et al. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion. Arterioscler Thromb Vasc Biol 2013;33:2180–6.
   PubMed Web of Science ®Google Scholar